ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,710Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 223

$858K Total Retail Price of All Prescriptions

Rank: 12 out of 223

434 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 434 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 434 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 11,650 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
LEVOTHYROXINE SODIUM 640 579 1 2
SIMVASTATIN 620 556 2 1
OMEPRAZOLE 484 425 3 3
GABAPENTIN 386 329 4 10
HYDROCODONE-ACETAMINOPHEN 384 306 S3 5 5
SPIRONOLACTONE 363 335 6 55
ZOLPIDEM TARTRATE 279 210 7 8
AMLODIPINE BESYLATE 269 239 8 6
FUROSEMIDE 256 248 9 9
LOSARTAN POTASSIUM 241 203 10 14
MELOXICAM 227 205 11 33
POTASSIUM CHLORIDE 221 204 12 12
METFORMIN HCL 201 183 13 7
HYDROCHLOROTHIAZIDE 197 177 14 13
FLUOXETINE HCL 188 163 15 24
LISINOPRIL 181 169 16 4
SERTRALINE HCL 173 166 17 21
WARFARIN SODIUM 170 158 18 11
ATENOLOL 168 159 19 32
ALLOPURINOL 166 159 20 28
FAMOTIDINE 158 133 21 151
FINASTERIDE 151 135 22 58
ZAFIRLUKAST 138 120 23 181
ROPINIROLE HCL 131 117 24 62
DONEPEZIL HCL 131 131 24 36
OLANZAPINE 122 101 26 102
FENTANYL 119 76 S2 27 91
GLIMEPIRIDE 108 108 28 30
HYDROXYCHLOROQUINE SULFATE 100 74 29 108
SINGULAIR 97 82 30 156
METFORMIN HCL ER 93 90 31 41
PREDNISONE 92 64 32 43
TRAMADOL HCL 90 85 33 18
ZALEPLON 86 64 34 208
CARISOPRODOL 84 64 R 35 63
AZITHROMYCIN 83 70 36 44
CARVEDILOL 81 80 37 23
PRAVASTATIN SODIUM 78 76 38 15
METOPROLOL TARTRATE 77 69 39 25
LANTUS 75 57 40 34
DIVALPROEX SODIUM 74 46 41 123
NEXIUM 74 63 41 49
CLOPIDOGREL 74 55 41 56
TAMSULOSIN HCL 74 73 41 26
ADVAIR DISKUS 72 64 45 47
POLYETHYLENE GLYCOL 3350 70 68 46 69
CYMBALTA 69 59 47 40
AGGRENOX 68 58 48 218
DIGOXIN 68 65 48 73
CITALOPRAM HBR 67 64 50 16
PANTOPRAZOLE SODIUM 66 42 51 45
MIRTAZAPINE 65 65 52 94
OXYCODONE HCL-ACETAMINOPHEN 64 23 S2 53 106
ATORVASTATIN CALCIUM 62 61 54 17
PROPRANOLOL HCL 62 46 54 93
ZETIA 62 59 54 68
BACLOFEN 60 36 57 184
CIPROFLOXACIN HCL 59 46 58 53
MONTELUKAST SODIUM 59 50 58 233
NITROFURANTOIN MONO-MACRO 57 53 60 236
COLESTIPOL HCL 57 57 60 236
CYCLOBENZAPRINE HCL 56 40 R 62 79
CELEBREX 56 41 62 42
SUMATRIPTAN SUCCINATE 55 28 64 151
METOCLOPRAMIDE HCL 54 42 65 185
NAMENDA 53 53 66 48
IBUPROFEN 51 38 67 46
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 28 68 113
BYSTOLIC 50 36 68 87
TRAZODONE HCL 50 38 68 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.